Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
European Journal of Immunology
|
October 1, 1991
Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge
L Norderhaug, O H Brekke, B Bremnes, et al.
British Journal of Cancer
|
March 28, 2013
Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008)
T Wahlgren, U Harmenberg, P Sandström, et al.
Acta Anaesthesiologica Scandinavica
|
August 13, 2005
Pre-operative fasting guidelines: an update
E Søreide, L I Eriksson, G Hirlekar, et al.
Acta Anaesthesiologica Scandinavica
|
July 1, 1996
Local anaesthesia and propofol-fentanyl sedation for carotid artery surgery
O Nordström, A Potemkowski, R Johansson, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research
|
August 2, 2018
Membrane-based pretreatment to mitigate variations in desalination plants
J Arevalo, R Sandin, M D Kennedy, et al.
Vaccine
|
March 6, 1999
Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine
L M Naess, T Aarvak, A Aase, et al.
Bone Marrow Transplantation
|
March 15, 2006
Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation
E Ayala, J Greene, R Sandin, et al.
ESMO Open
|
June 17, 2022
Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
B Tombal, C N Sternberg, M Hussain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2014
Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma
S Négrier, A G Bushmakin, J C Cappelleri, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
European Journal of Immunology
|
October 1, 1991
Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge
L Norderhaug, O H Brekke, B Bremnes, et al.
British Journal of Cancer
|
March 28, 2013
Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008)
T Wahlgren, U Harmenberg, P Sandström, et al.
Acta Anaesthesiologica Scandinavica
|
August 13, 2005
Pre-operative fasting guidelines: an update
E Søreide, L I Eriksson, G Hirlekar, et al.
Acta Anaesthesiologica Scandinavica
|
July 1, 1996
Local anaesthesia and propofol-fentanyl sedation for carotid artery surgery
O Nordström, A Potemkowski, R Johansson, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research
|
August 2, 2018
Membrane-based pretreatment to mitigate variations in desalination plants
J Arevalo, R Sandin, M D Kennedy, et al.
Vaccine
|
March 6, 1999
Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine
L M Naess, T Aarvak, A Aase, et al.
Bone Marrow Transplantation
|
March 15, 2006
Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation
E Ayala, J Greene, R Sandin, et al.
ESMO Open
|
June 17, 2022
Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
B Tombal, C N Sternberg, M Hussain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2014
Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma
S Négrier, A G Bushmakin, J C Cappelleri, et al.
Page
of 5